secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vir Biotechnology, Inc. (VIR)
CIK:        0001706431
Form:       8-K
Filed at:   2023-03-13T23:59:59+00:00
Accession:  0001193125-23-067978
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Vir Biotechnology discloses $220M exposure to Silicon Valley Bank after FDIC seizure
--------------------------------------------------------------------------------

- FDIC took control of Silicon Valley Bank (SVB) on March 10, 2023.
- Vir holds approximately $220 million in operating accounts at SVB as of March 10.
- Total cash, cash equivalents and investments were $2.4 billion as of December 31, 2022.
- Company is monitoring the situation but has not disclosed any impact on operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1706431/000119312523067978/0001193125-23-067978-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1706431/000119312523067978/d409774d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-067978

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer